Beacon Therapeutics
BiotechnologyAlachua, FL
Total funding$365M#2 of 32 in Biotechnology
Founded2023
SectorBiotechnology
HQAlachua
About
Beacon Therapeutics is a biotechnology firm in the clinical stage focused on preserving and enhancing vision for individuals affected by both uncommon and widespread eye disorders. The organization is leveraging the revolutionary potential of gene therapy to achieve significant results for serious eye conditions. Currently, Beacon's pipeline is aimed at severe retinal diseases that cause blindness, including X-linked retinitis pigmentosa (XLRP) and geographic atrophy.
Beacon Therapeutics is one of 3 Biotechnology companies we track in Gainesville — 20% of the region's 15 startups.
Similar companies
View allAscend Advanced TherapiesBiotechnology | Est. 2022 | GNV | $131M |
Lacerta TherapeuticsBiotechnology | Est. 2017 | GNV | $30M |
ASP IsotopesBiotechnology | Est. 2021 | MIA | $372M |
SyncromuneBiotechnology | Est. 2020 | MIA | $155M |
Pasithea TherapeuticsBiotechnology | Est. 2020 | MIA | $104M |
Details
- City
- Alachua
- Founded
- 2023
- Sector
- Biotechnology
- Founders
- Robert MacLaren
- Website
- beacontx.com
Gainesville / North Central
Gainesville and North Central Florida cluster around UF research — biotech, agtech, and lab hardware, with a steady stream of university spinouts.
15companies
$612Mraised